Supriya Peshin
banner
supriyapeshin.bsky.social
Supriya Peshin
@supriyapeshin.bsky.social
Resident Physician at Ballad Health | Aspiring Hematologist & Oncologist with a special passion for Gastrointestinal Oncology | Deeply engaged in oncology research and dedicated to advancing the field.
Reposted by Supriya Peshin
Great Women Leaders in Oncology (and allies) event last night at #asco25. Such energy in the room! @conquercancer.bsky.social @ascocancer.bsky.social @rachnatshroff.bsky.social
June 3, 2025 at 2:28 PM
Reposted by Supriya Peshin
#asco25 President’s dinner at the Field Museum with @ascocancer.bsky.social presidents past and future - Lori Pierce & Beth Mittendorf @rachnatshroff.bsky.social
June 1, 2025 at 3:07 PM
Reposted by Supriya Peshin
The best in #GIonc trials to look for at #ASCO25. 2⃣ plenary talks that will revolutionize #crcsm and #esocsm #stmcsm. Can't wait to take this best of science into the clinic!

@oncoalert.bsky.social
@weoncologists.bsky.social
@pallonccop.bsky.social
@biagioricciutimd.bsky.social
The #ASCO25 #OncoAlertTOP10 Abstracts in GI Oncology
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@realbowtiedoc.bsky.social
@arosen380.bsky.social
Ping
‪@gillsharlene.bsky.social‬
May 26, 2025 at 9:41 AM
Reposted by Supriya Peshin
The most clinically relevant science in oncology will be presented at #ASCO25, and you can now view the full 5,000 abstracts & their presentation date, time & location info: brnw.ch/21wSRrH
May 22, 2025 at 10:00 PM
Honored to be part of it . Thank you @ascocancer.bsky.social for giving me this opportunity
Thrilled to announce our Annual Meeting Featured Voices! Get ready for a wealth of expert perspectives and engaging discussions throughout the meeting. Don't miss out – follow along and contribute to the conversation using the official hashtag: #ASCO25
May 5, 2025 at 5:25 PM
Reposted by Supriya Peshin
A comprehensive review of #pancsm in
@thelancet.bsky.social

Underscores current 🚧
🌟 Discusses future promise 🌟
Emphasizes need for #novel 🎯

🔗: thelancet.com/journals/lan... #GIonc

@biagioricciutimd.bsky.social
@drnataliagandur.bsky.social
@barbaramelao.bsky.social
@kjankovic.bsky.social
April 30, 2025 at 5:39 PM
Publication alert ‼️ 🔔Large retrospective analysis of 153 #PCL patients using new definition of ≥ 5% circulating plasma cells finds secondary PCL associated with a worse prognosis, with median OS of 3.2 months vs 36.6 months for primary PCL: pubmed.ncbi.nlm.nih.gov/40241568/@oncodaily.bsky.social
Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study - PubMed
Plasma cell leukemia (PCL) is a rare and aggressive plasma cell disorder with a short survival duration despite the use of novel therapeutics. PCL remains an understudied disease for which there is no...
pubmed.ncbi.nlm.nih.gov
April 28, 2025 at 1:04 AM
Reposted by Supriya Peshin
Nothing gives me a boost like meeting with my @pallonccop.bsky.social family. Combine that with my love of #nerdy 🤓 and this is going to be a dynamite collaboration. Make sure you don't miss out next week. Join us! #hpm #hapc #pallonc #supponc #AI #healthIT #oncsky #medsky
April 22, 2025 at 6:18 PM
Reposted by Supriya Peshin
Finally getting some spring weather in the #Midwest 🌞🌞🌹🥀🌻 on #BowTieFriday. Looking forward to #ASCO25 with abstract release this week. What are you looking forward to?

@docwithbowtie.bsky.social
@engagetheo.bsky.social
@djweiner.bsky.social
@stephjantzen.bsky.social
@zachradcliffphd.bsky.social
April 25, 2025 at 4:06 PM
Reposted by Supriya Peshin
ICYMI: Small studies in prostate cancer suggest that intermittent androgen deprivation therapy or treatment breaks may be an option for certain patients. Drs. Jordan Ciuro, Mehmet Asim Bilen, and Shahid Ahmed discuss de-escalation decisions for #ASCODailyNews: brnw.ch/21wS0JZ
April 15, 2025 at 4:04 PM
Reposted by Supriya Peshin
Your research could impact the quality of life of a peer or patient. Share your insights or data-driven solutions with an audience that shares your passion for high-quality oncology care and workplace health.

Submit your abstract to #ASCOQLTY25 today: brnw.ch/21wS21S
April 16, 2025 at 2:00 PM